Showing results (101-110 of 256) with videos related to

Sort By:
Pageof 26
Arthritis and Rheumatism|April 11, 2003
Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative studyMariette C Lodder, Glenn Haugeberg, Willem F Lems, et al.
Arthritis and Rheumatism|September 29, 2011
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reductionDebby den Uyl, Daniel H van Raalte, Michael T Nurmohamed, et al.
The Journal of Rheumatology|June 3, 2009
Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation studyLilian H D van Tuyl, Anne Marie C Plass, Willem F Lems, et al.
The Journal of Rheumatology|August 4, 2004
Serological bone markers and joint damage in early polyarthritisLouise M A Jansen, Irene van der Horst-Bruinsma, Willem F Lems, et al.
The Journal of Rheumatology|September 1, 2004
Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritisSerge C L M Cremers, Mariëtte C Lodder, Jan Den Hartigh, et al.
The Journal of Rheumatology|February 17, 2016
Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort StudyMaria A C van der Weijden, J Christiaan van Denderen, Willem F Lems, et al.
Annals of the Rheumatic Diseases|July 8, 2009
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort studyG M Bartelds, C A Wijbrandts, M T Nurmohamed, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 20, 2011
High frequency of vertebral fractures in early spondylarthropathiesM A C van der Weijden, I E van der Horst-Bruinsma, J C van Denderen, et al.
Annals of the Rheumatic Diseases|November 12, 2010
The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanerceptAnna Jamnitski, Geertje M Bartelds, Michael T Nurmohamed, et al.
Arthritis and Rheumatism|July 28, 2011
Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritisLotte A van de Stadt, Margret H M T de Koning, Rob J van de Stadt, et al.
Pageof 26